These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23837923)

  • 1. Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections.
    Magis-Escurra C; Alffenaar JW; Hoefnagels I; Dekhuijzen PN; Boeree MJ; van Ingen J; Aarnoutse RE
    Int J Antimicrob Agents; 2013 Sep; 42(3):256-61. PubMed ID: 23837923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
    Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
    Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
    Sharma M; Malhotra B; Khandelwal S
    Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Other Nontuberculous Mycobacteria.
    Basille D; Jounieaux V; Andréjak C
    Semin Respir Crit Care Med; 2018 Jun; 39(3):377-382. PubMed ID: 30071552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study.
    Kurosawa K; Rossenu S; Biewenga J; Ouwerkerk-Mahadevan S; Willems W; Ernault E; Kambili C
    J Clin Pharmacol; 2021 Oct; 61(10):1344-1355. PubMed ID: 33991350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of gliclazide and rifampicin.
    Kihara Y; Otsuki M
    Diabetes Care; 2000 Aug; 23(8):1204-5. PubMed ID: 10937528
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
    Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
    Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
    Tomiyama Y; Maesaki S; Yong B; Higashiyama Y; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The development of pneumothorax in an elderly woman during treatment for nontuberculous mycobacterium].
    Ando K; Ishii M; Yonenaga A; Shibasaki K; Yamaguchi Y; Urano T; Ogawa S; Akishita M
    Nihon Ronen Igakkai Zasshi; 2018; 55(1):136-142. PubMed ID: 29503357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
    van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
    Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin.
    Magis-Escurra C; Later-Nijland HM; Alffenaar JW; Broeders J; Burger DM; van Crevel R; Boeree MJ; Donders AR; van Altena R; van der Werf TS; Aarnoutse RE
    Int J Antimicrob Agents; 2014 Sep; 44(3):229-34. PubMed ID: 24985091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada.
    Damaraju D; Jamieson F; Chedore P; Marras TK
    Int J Tuberc Lung Dis; 2013 May; 17(5):676-81. PubMed ID: 23575335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.